Global Edition news
August 13, 2019
Baze, a subscription platform that ships personalized vitamin supplement packages based on home blood test results, has raised $6 million in Series A funding. Supplement and wellness product manufacturer Nature’s Way headed the investment.
WHAT THEY DO
Looking to cut back on unnecessary supplement consumption and the costs it ensues, Baze’s direct-to-consumer service first tests the user to see...
August 9, 2019
Fitbit’s latest earnings call was a mixed bag for the wearable giant. The company’s revenue and device sales were up; however, the average price of the devices was down. This has led to the company to lower its revenue guidance by $95 million.
It appears to be continuing to focus in on its health division, which is seeing an uptick in year-over-year revenue, and is on track to meet its $100...
August 8, 2019
Practices using DrChrono’s digital EHRs will now be able to incorporate OutcomeMD’s patient reported outcome tool within their workflows, thanks to a new partnership between the two companies. The functionality automatically pushes symptom and pain information submitted through patient devices to the clinician’s EHR medical note, is supported for 20 different medical specialties, including...
August 8, 2019
Earlier this week LifeOmic, maker of a provider-facing data integration app, announced a new platform dubbed LIFE Extend that's designed to help patients prevent chronic disease associated with aging.
The app gives users points for tracking their physical activity, nutrition, mindfulness, sleep and intermittent fasting. Once a user acquires a certain amount of points, they can cash them at...
August 7, 2019
Sitata, a service that supports international travelers with safety and health information relevant to their trip, has relaunched its platform with a host of new features, key among which is support for in-app telemedicine visits with a network of vetted travel physicians.
“We knew we do a lot of preventative health information, but when it came to assisting someone in time of need, we weren’t...
August 6, 2019
Paris, France-based Voluntis has received FDA marketing authorization for an algorithm-driven digital tool that helps cancer patients manage their symptoms and care teams identify clinical insights, the company announced last week.
The Oleena software is a Class II medical device that is prescribed by the patient’s care team. As the user logs their symptoms into the app, it adapts to offer...
August 1, 2019
Thriva, a London-based platform providing mail-order blood tests for consumers, has raised another $7.3 million in backing thanks to a new Series A round. Pembroke VCT and Guinness Asset Management were among the round’s participants, which brought the company’s total funds raised to $8.2 million.
WHAT THEY DO
Since 2016, Thriva has offered mail-order tests and results interpretations to more...
July 30, 2019
Infant development platform BabySparks has closed a $2 million in seed funding, the startup announced on Friday. Ocean Azul Partners headed the round, which also included participation from Miami Angels, Kairos, Marstar Investments, Lou Kreisberg and Steve Goodman.
WHAT THEY DO
BabySparks has built an app-based tool for parents to track and stimulate the development of their young children. After...
July 25, 2019
Healthcare artificial intelligence company Viz.ai announced that it is joining forces with Medtronic with the goal of speeding up adoption of the former’s technology. Specifically the pair will be working on getting Viz.ai’s system, which specializes on stroke detection, into more stroke treatment centers in the US.
“Medtronic is an innovative company focused on therapies that extend life and...
July 24, 2019
Australian digital health company PainChek recently announced that the United States Patent Office has issued a Notice of Allowance for its pain assessment invention. This means that patent prosecution has been successfully completed.
The U.S. patent, when granted, gives PainChek exclusive rights to exclude others from making, using, selling or importing the invention for 20 years from the...